Khaled, N. B., Ehmer, U., Kubisch, I., Gonzalez-Carmona, M. A., Philipp, A. B., Seidensticker, M., Geier, A., Soldà, C., Auriemma, A., Schulze, K., Antonuzzo, L., Masi, G., Daniele, B., Ricke, J., Mayerle, J., Foerster, F., Reiter, F. P., Ettrich, T. J., Toni, E. D. (2025). Sequential or up-front triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma (AIO-MONTBLANC): Safety interim analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4122